Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

2.730 -0.160 (-5.54%)
Streaming Delayed Price Updated: 12:11 PM EST, Nov 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Treace Medical Concepts, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) BioCryst Pharmaceuticals,... 
Via Benzinga
News headline image
Earnings Scheduled For May 25, 2021 ↗
Companies Reporting Before The Bell • Elbit Systems (NASDAQ:ESLT) is likely to report quarterly earnings at $1.40 per share on revenue of $1.10 billion. • Burning... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2021 ↗
Upgrades Seaport Global upgraded the previous rating for Public Service Enterprise Group Inc (NYSE:PEG) from Neutral to Buy. Public Service Enterprise earned $1.28 in the... 
Via Benzinga
News headline image
Treace Medical's Lapiplasty 3D Associated With Early Weightbearing After Foot Surgery, Interim Data Shows ↗
Medical device company Treace Medical Concepts Inc (NASDAQ: TMCI) has announced interim results from the ALIGN3D clinical study, a post-market 5-year study... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021 ↗
Upgrades Janney Montgomery Scott upgraded the previous rating for Centerspace (NYSE:CSR) from Neutral to Buy. In the first quarter, Centerspace showed an EPS of $0.95,... 
Via Benzinga
News headline image
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off ↗
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the... 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
News headline image
38 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) surged 46.9% to $6.25 after the company announced the full details of its Phase 2 trial evaluating its lead drug... 
Via Benzinga
News headline image
58 Biggest Movers From Yesterday ↗
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial... 
Via Benzinga
News headline image
50 Biggest Movers From Friday ↗
Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares surged 59.1% to close at $4.47 on Friday after the company said its electronics unit has won a contract for deep space... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.